Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ioflupane
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ioflupane is a Radiolabeled Compounds drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Radiolabeled Compound
Upfront Cash : Inapplicable
September 25, 2020
Lead Product(s) : Ioflupane
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ioflupane is a Radiolabeled Compounds drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Parkinsonian Disorders.
Product Name : Undisclosed
Product Type : Radiolabeled Compound
Upfront Cash : Inapplicable
December 10, 2019